Trial Site Detail

 

Drug:
Regorafenib (SDH)
Trial:
Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST (REGISTRI)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

Hospital Vall d'Hebron

119-129     
Barcelona , 08035
Spain

 

Principal Investigator:
Claudia Valverde, MD
Contact:
Activation Status of this Site:
Active
Notes about this Site:
Hospital Vall d'Hebron Website:
http://www.vhebron.es/vhang.htm

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.